Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
Medical Society Letter about Anthem Policy on Use of Nonparticipating Care Providers
-
Sign-on Letter to Evicore Regarding Interpretation of NCCN Guidelines
-
ACMG Response to PLUGS on Framework for Development of Payer Medical Necessity Policy
-
Stakeholder Letter Supporting Joint Resolutions to Overturn FDA Rule on LDTs
-
ACMG Response to Senate HELP Committee RFI on Diagnostics Regulation
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
ACMG Comments on FDA Proposed Rule for Regulation of LDTs